Top

Published in:

Open Access 01-09-2020 | Brachytherapy | Review Article

DEGRO practical guideline for partial-breast irradiation

Authors: V. Strnad, D. Krug, F. Sedlmayer, M. D. Piroth, W. Budach, R. Baumann, P. Feyer, M. N. Duma, W. Haase, W. Harms, T. Hehr, R. Fietkau, J. Dunst, R. Sauer, Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO)

Published in: Strahlentherapie und Onkologie | Issue 9/2020

Abstract

Purpose

This consensus statement from the Breast Cancer Working Group of the German Society for Radiation Oncology (DEGRO) aims to define practical guidelines for accelerated partial-breast irradiation (APBI).

Methods

Recent recommendations for relevant aspects of APBI were summarized and a panel of experts reviewed all the relevant literature. Panel members of the DEGRO experts participated in a series of conferences, supplemented their clinical experience, performed a literature review, and formulated recommendations for implementing APBI in clinical routine, focusing on patient selection, target definition, and treatment technique.

Results

Appropriate patient selection, target definition for different APBI techniques, and basic rules for appropriate APBI techniques for clinical routine outside of clinical trials are described. Detailed recommendations for APBI in daily practice, including dose constraints, are given.

Conclusion

Guidelines are mandatory to assure optimal results of APBI using different techniques.

Strnad V, Ott OJ, Hildebrandt G et al (2016) 5‑year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial. Lancet 387(10015):229–238PubMed

Coles CE, Griffin CL, Kirby AM et al (2017) Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5‑year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial. Lancet 390(10099):1048–1060PubMedPubMedCentral

Polgar C, Ott OJ, Hildebrandt G et al (2017) Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5‑year results of a randomised, controlled, phase 3 trial. Lancet Oncol 18(2):259–268PubMed

Schafer R, Strnad V, Polgar C et al (2018) Quality-of-life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation in early breast cancer after breast-conserving surgery (GEC-ESTRO): 5‑year results of a randomised, phase 3 trial. Lancet Oncol 19(6):834–844PubMed

Livi L, Meattini I, Marrazzo L et al (2015) Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5‑year survival analysis of a phase 3 randomised controlled trial. Eur J Cancer 51(4):451–463PubMed

Polgar C, Fodor J, Major T, Sulyok Z, Kasler M (2013) Breast-conserving therapy with partial or whole breast irradiation: ten-year results of the Budapest randomized trial. Radiother Oncol 108(2):197–202PubMed

Clarke M, Collins R, Darby S et al (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366(9503):2087–2106PubMed

Coles CE, Yarnold JR (2016) Accelerated partial breast irradiation: the new standard? Lancet 387(10015):201–202PubMed

Lettmaier S, Kreppner S, Lotter M et al (2011) Radiation exposure of the heart, lung and skin by radiation therapy for breast cancer: a dosimetric comparison between partial breast irradiation using multicatheter brachytherapy and whole breast teletherapy. Radiother Oncol 100(2):189–194PubMed

10.

Hoekstra N, Fleury E, Merino LTR et al (2018) Long-term risks of secondary cancer for various whole and partial breast irradiation techniques. Radiother Oncol 128(3):428–433PubMed

11.

Piroth MD, Baumann R, Budach W et al (2019) Heart toxicity from breast cancer radiotherapy: current findings, assessment, and prevention. Strahlenther Onkol 195(1):1–12PubMed

12.

Vicini FACR, White JR, Julian TB, Arthur DW, Rabinovitch RA, Kuske RR, Parda DS, Ganz PA, Scheier MF, Winter KA, Paik S, Kuerer HM, Vallow LA, Pierce LJ, Mamounas EP, Costantino JP, Bear HD, Germaine I, Gustafson G, Grossheim L, Petersen IA, Hudes RS, Curran WJ Jr., Wolmark N (2018) Primary results of NSABP B‑39/RTOG 0413 (NRG Oncology): a randomized phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) for women with stage 0, I, or II breast cancer. In: 41st Annual San Antonion Breast Cancer Symposium 41st Annual San Antonion Breast Cancer Symposium, December 4‑10 (Abstract GS4-04), San Antonio 2019

13.

Whelan TJJ, Levine M, Berrang T, Kim D‑H, Gu CS, Germain I, Nichol A, Akra M, Lavertu S, Germain F, Fyles A, Trotter T, Perera F, Balkwill S, Chafe S, McGowan T, Muanza T, Beckham W, Chua B, Olivotto IRAPID (2018) A randomized trial of accelerated partial breast irradiation using 3‑dimensional conformal radiotherapy (3D-CRT). In: 41th San Antonio Breast Cancer Symposium 41th San Antonio Breast Cancer Symposium, December 4‑8 (Abstract GS4-03), San Antonio 2019

14.

Vaidya JS, Wenz F, Bulsara M et al (2014) Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5‑year results for local control and overall survival from the TARGIT‑A randomised trial. Lancet 383(9917):603–613PubMed

15.

Veronesi U, Orecchia R, Maisonneuve P et al (2013) Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial. Lancet Oncol 14(13):1269–1277PubMed

16.

Rodriguez N, Sanz X, Dengra J et al (2013) Five-year outcomes, cosmesis, and toxicity with 3‑dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 87(5):1051–1057PubMed

17.

Vicini FA, Cecchini RS, White JR et al (2019) Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial. Lancet 394(10215):2155–2164PubMed

18.

Whelan TJ, Julian JA, Berrang TS et al (2019) External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial. Lancet 394(10215):2165–2172PubMed

19.

Krug D, Dunst J (2019) Whole- or partial-breast radiotherapy after 5 years from a patient perspective: longitudinal analysis of the IMPORT LOW (CRUK/06/003) phase III trial. Strahlenther Onkol 195(8):767–768PubMed

20.

Coles CE, Wilson CB, Cumming J et al (2009) Titanium clip placement to allow accurate tumour bed localisation following breast conserving surgery: audit on behalf of the IMPORT Trial Management Group. Eur J Surg Oncol 35(6):578–582PubMed

21.

Olivotto IA, Whelan TJ, Parpia S et al (2013) Interim cosmetic and toxicity results from RAPID: a randomized trial of accelerated partial breast irradiation using three-dimensional conformal external beam radiation therapy. J Clin Oncol 31(32):4038–4045PubMed

22.

Correa C, Harris EE, Leonardi MC et al (2017) Accelerated partial breast irradiation: executive summary for the update of an ASTRO evidence-based consensus statement. Pract Radiat Oncol 7(2):73–79PubMed

23.

Polgar C, Major T, Fodor J et al (2010) Accelerated partial-breast irradiation using high-dose-rate interstitial brachytherapy: 12-year update of a prospective clinical study. Radiother Oncol 94(3):274–279PubMed

24.

Leonardi MC, Maisonneuve P, Mastropasqua MG et al (2012) How do the ASTRO consensus statement guidelines for the application of accelerated partial breast irradiation fit intraoperative radiotherapy? A retrospective analysis of patients treated at the European Institute of Oncology. Int J Radiat Oncol Biol Phys 83(3):806–813PubMed

25.

Leonardi MC, Maisonneuve P, Mastropasqua MG et al (2013) Accelerated partial breast irradiation with intraoperative electrons: using GEC-ESTRO recommendations as guidance for patient selection. Radiother Oncol 106(1):21–27PubMed

26.

Maluta S, Dall’Oglio S, Marciai N et al (2012) Accelerated partial breast irradiation using only intraoperative electron radiation therapy in early stage breast cancer. Int J Radiat Oncol Biol Phys 84(2):e145–152PubMed

27.

Vaidya JS, Wenz F, Bulsara M et al (2016) An international randomised controlled trial to compare TARGeted Intraoperative radioTherapy (TARGIT) with conventional postoperative radiotherapy after breast-conserving surgery for women with early-stage breast cancer (the TARGIT‑A trial). Health Technol Assess 20(73):1–188PubMedPubMedCentral

28.

Corica T, Nowak AK, Saunders CM et al (2016) Cosmesis and breast-related quality of life outcomes after Intraoperative radiation therapy for early breast cancer: a substudy of the TARGIT‑A trial. Int J Radiat Oncol Biol Phys 96(1):55–64PubMed

29.

Corica T, Nowak AK, Saunders CM et al (2018) Cosmetic outcome as rated by patients, doctors, nurses and BCCT.core software assessed over 5 years in a subset of patients in the TARGIT‑A Trial. Radiat Oncol 13(1):68PubMedPubMedCentral

30.

Abo-Madyan Y, Welzel G, Sperk E et al (2019) Single-center long-term results from the randomized phase‑3 TARGIT‑A trial comparing intraoperative and whole-breast radiation therapy for early breast cancer. Strahlenther Onkol 195(7):640–647PubMed

31.

Hepel J, Wazer DE (2015) A flawed study should not define a new standard of care. Int J Radiat Oncol Biol Phys 91(2):255–257PubMed

32.

Silverstein MJ, Fastner G, Maluta S et al (2014) Intraoperative radiation therapy: a critical analysis of the ELIOT and TARGIT trials. Part 2—TARGIT. Ann Surg Oncol 21(12):3793–3799PubMedPubMedCentral

33.

Zietman A. Letters Regarding the TARGIT‑A Trial (2015) The editor’s introduction. Int J Radiat Oncol Biol Phys 92(5):951–952

34.

Vaidya JS, Bulsara M, Wenz F et al (2015) Pride, prejudice, or science: attitudes towards the results of the TARGIT‑A trial of targeted Intraoperative radiation therapy for breast cancer. Int J Radiat Oncol Biol Phys 92(3):491–497PubMedPubMedCentral

35.

Shah C, Wobb J, Khan A (2016) Intraoperative radiation therapy in breast cancer: still not ready for prime time. Ann Surg Oncol 23(6):1796–1798PubMed

36.

Cuzick J (2014) Radiotherapy for breast cancer, the TARGIT‑A trial. Lancet 383(9930):1716PubMed

37.

National Institute for Health and Care Excellence Intrabeam radiotherapy system for adjuvant treatment of early breast cancer. Technology appraisal guidance. https://www.nice.org.uk/guidance/ta501. Last access: 31 Jan 2018

38.

Thompson MK, Poortmans P, Chalmers AJ et al (2018) Practice-changing radiation therapy trials for the treatment of cancer: where are we 150 years after the birth of Marie Curie? Br J Cancer 119(4):389–407PubMedPubMedCentral

39.

Shah C, Vicini F, Wazer DE, Arthur D, Patel RR (2013) The American Brachytherapy Society consensus statement for accelerated partial breast irradiation. Brachytherapy 12(4):267–277PubMed

40.

41.

Huang J, Barbera L, Brouwers M, Browman G, Mackillop WJ (2003) Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. J Clin Oncol 21(3):555–563PubMed

42.

Recht A, Come SE, Gelman RS et al (1991) Integration of conservative surgery, radiotherapy, and chemotherapy for the treatment of early-stage, node-positive breast cancer: sequencing, timing, and outcome. J Clin Oncol 9(9):1662–1667PubMed

43.

Hebert-Croteau N, Freeman CR, Latreille J, Brisson J (2002) Delay in adjuvant radiation treatment and outcomes of breast cancer—a review. Breast Cancer Res Treat 74(1):77–94PubMed

44.

Froud PJ, Mates D, Jackson JS et al (2000) Effect of time interval between breast-conserving surgery and radiation therapy on ipsilateral breast recurrence. Int J Radiat Oncol Biol Phys 46(2):363–372PubMed

45.

Nixon AJ, Recht A, Neuberg D et al (1994) The relation between the surgery-radiotherapy interval and treatment outcome in patients treated with breast-conserving surgery and radiation therapy without systemic therapy. Int J Radiat Oncol Biol Phys 30(1):17–21PubMed

46.

Olivotto IA, Lesperance ML, Truong PT et al (2009) Intervals longer than 20 weeks from breast-conserving surgery to radiation therapy are associated with inferior outcome for women with early-stage breast cancer who are not receiving chemotherapy. J Clin Oncol 27(1):16–23PubMed

47.

Mikeljevic JS, Haward R, Johnston C et al (2004) Trends in postoperative radiotherapy delay and the effect on survival in breast cancer patients treated with conservation surgery. Br J Cancer 90(7):1343–1348PubMedPubMedCentral

48.

Cefaro GA, Genovesi D, Marchese R et al (2007) The effect of delaying adjuvant radiation treatment after conservative surgery for early breast cancer. Breast J 13(6):575–580PubMed

49.

van Maaren MC, Bretveld RW, Jobsen JJ et al (2017) The influence of timing of radiation therapy following breast-conserving surgery on 10-year disease-free survival. Br J Cancer 117(2):179–188PubMedPubMedCentral

50.

Vicini F, Shah C, Arthur D, Khan A, Wazer D, Keisch M (2016) Partial breast irradiation and the GEC-ESTRO trial. Lancet 387(10029):1717–1718PubMed

51.

Chen PY, Vicini FA (2007) Partial breast irradiation. Patient selection, guidelines for treatment, and current results. Front Radiat Ther Oncol 40:253–271PubMed

52.

Shaitelman SF, Lin HY, Smith BD et al (2016) Practical implications of the publication of consensus guidelines by the American society for radiation oncology: accelerated partial breast irradiation and the national cancer data base. Int J Radiat Oncol Biol Phys 94(2):338–348PubMed

53.

Polgar C, Van Limbergen E, Potter R et al (2010) Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Europeen de Curietherapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009). Radiother Oncol 94(3):264–273PubMed

54.

Smith BD, Arthur DW, Buchholz TA et al (2009) Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys 74(4):987–1001PubMed

55.

Smith BD, Arthur DW, Buchholz TA et al (2009) Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). J Am Coll Surg 209(2):269–277PubMed

56.

Miranda FA, Teixeira LAB, Heinzen RN et al (2019) Accelerated partial breast irradiation: current status with a focus on clinical practice. Breast J 25(1):124–128PubMed

57.

Strnad V, Hannoun-Levi JM, Guinot JL et al (2015) Recommendations from GEC ESTRO breast cancer working group (I): target definition and target delineation for accelerated or boost partial breast irradiation using multicatheter interstitial brachytherapy after breast conserving closed cavity surgery. Radiother Oncol 115(3):342–348PubMed

58.

Major T, Gutierrez C, Guix B et al (2016) Recommendations from GEC ESTRO breast cancer working group (II): target definition and target delineation for accelerated or boost partial breast irradiation using multicatheter interstitial brachytherapy after breast conserving open cavity surgery. Radiother Oncol 118(1):199–204PubMed

59.

Swanson TA, Vicini FA (2008) Overview of accelerated partial breast irradiation. Curr Oncol Rep 10(1):54–60PubMed

60.

Offersen BV, Overgaard M, Kroman N, Overgaard J (2009) Accelerated partial breast irradiation as part of breast conserving therapy of early breast carcinoma: a systematic review. Radiother Oncol 90(1):1–13PubMed

61.

Strom EA, Ovalle V (2014) Initial clinical experience using protons for accelerated partial-breast irradiation: longer-term results. Int J Radiat Oncol Biol Phys 90(3):506–508PubMed

62.

Formenti SC, Hsu H, Fenton-Kerimian M et al (2012) Prone accelerated partial breast irradiation after breast-conserving surgery: five-year results of 100 patients. Int J Radiat Oncol Biol Phys 84(3):606–611PubMedPubMedCentral

63.

Jozsef G, DeWyngaert JK, Becker SJ, Lymberis S, Formenti SC (2011) Prospective study of cone-beam computed tomography image-guided radiotherapy for prone accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 81(2):568–574PubMed

64.

Wen B, Hsu H, Formenti-Ujlaki GF et al (2012) Prone accelerated partial breast irradiation after breast-conserving surgery: compliance to the dosimetry requirements of RTOG-0413. Int J Radiat Oncol Biol Phys 84(4):910–916PubMed

65.

Kainz K, White J, Herman J, Li XA (2009) Investigation of helical tomotherapy for partial-breast irradiation of prone-positioned patients. Int J Radiat Oncol Biol Phys 74(1):275–282PubMed

66.

White JR, Meyer JL (2011) Intensity-modulated radiotherapy for breast cancer: advances in whole and partial breast treatment. Front Radiat Ther Oncol 43:292–314PubMed

67.

Marrazzo L, Meattini I, Arilli C et al (2019) Auto-planning for VMAT accelerated partial breast irradiation. Radiother Oncol 132:85–92PubMed

68.

Lozza L, Fariselli L, Sandri M et al (2018) Partial breast irradiation with CyberKnife after breast conserving surgery: a pilot study in early breast cancer. Radiat Oncol 13(1):49PubMedPubMedCentral

69.

Obayomi-Davies O, Kole TP, Oppong B et al (2016) Stereotactic accelerated partial breast irradiation for early-stage breast cancer: rationale, feasibility, and early experience using the CyberKnife radiosurgery delivery platform. Front Oncol 6:129PubMedPubMedCentral

70.

Stelczer G, Major T, Meszaros N, Polgar C, Pesznyak C (2019) External beam accelerated partial breast irradiation: dosimetric assessment of conformal and three different intensity modulated techniques. Radiol Oncol 53(1):123–130PubMedPubMedCentral

71.

Stelczer G, Tatai-Szabo D, Major T et al (2019) Measurement of dose exposure of image guidance in external beam accelerated partial breast irradiation: evaluation of different techniques and linear accelerators. Phys Med 63:70–78PubMed

72.

Shah C, Badiyan S, Wilkinson BJ et al (2013) Treatment efficacy with accelerated partial breast irradiation (APBI): final analysis of the American Society of Breast Surgeons MammoSite((R)) breast brachytherapy registry trial. Ann Surg Oncol 20(10):3279–3285PubMed

73.

Yashar C, Attai D, Butler E et al (2016) Strut-based accelerated partial breast irradiation: report of treatment results for 250 consecutive patients at 5 years from a multicenter retrospective study. Brachytherapy 15(6):780–787PubMed

74.

Altman MB, Mooney KE, Edward S et al (2018) Efficiency of using the day-of-implant CT for planning of SAVI APBI. Brachytherapy 17(1):40–49PubMed

75.

Ivanov O, Dickler A, Lum BY, Pellicane JV, Francescatti DS (2011) Twelve-month follow-up results of a trial utilizing Axxent electronic brachytherapy to deliver intraoperative radiation therapy for early-stage breast cancer. Ann Surg Oncol 18(2):453–458PubMed

76.

Huang YJ, Su FF, Gaffney DK et al (2018) Skin dose estimation using virtual structures for Contura Multi-Lumen Balloon breast brachytherapy. Brachytherapy 17(6):956–965PubMed

77.

Pignol JP, Caudrelier JM, Crook J, McCann C, Truong P, Verkooijen HA (2015) Report on the clinical outcomes of permanent breast seed implant for early-stage breast cancers. Int J Radiat Oncol Biol Phys 93(3):614–621PubMed

78.

Arthur DW, Vicini FA, Todor DA, Julian TB, Cuttino LW, Mukhopadhyay ND (2013) Contura Multi-Lumen Balloon breast brachytherapy catheter: comparative dosimetric findings of a phase 4 trial. Int J Radiat Oncol Biol Phys 86(2):264–269PubMed

79.

Kirisits C, Rivard MJ, Baltas D et al (2014) Review of clinical brachytherapy uncertainties: analysis guidelines of GEC-ESTRO and the AAPM. Radiother Oncol 110(1):199–212PubMedPubMedCentral

80.

King TA, Bolton JS, Kuske RR, Fuhrman GM, Scroggins TG, Jiang XZ (2000) Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is,1,2) breast cancer. Am J Surg 180(4):299–304PubMed

81.

Strnad V, Hildebrandt G, Potter R et al (2011) Accelerated partial breast irradiation: 5‑year results of the German-Austrian multicenter phase II trial using interstitial multicatheter brachytherapy alone after breast-conserving surgery. Int J Radiat Oncol Biol Phys 80(1):17–24PubMed

82.

Strnad V (2014) Breast cancer. In: Strnad V, Pötter R, Kovács G (eds) Practical handbook of brachytherapy. UNIMED, Hamburg, pp 184–199

83.

Das RK, Thomandsen B (2009) Physics of accelerated partial breast irradiation. In: Wazer (ed) Accelerated partial breast irradiation. DG Arthur, FA ViciniSpringer Berlin-Heidelberg, DE, pp 73–99

84.

Strnad V, Major T, Polgar C et al (2018) ESTRO-ACROP guideline: interstitial multi-catheter breast brachytherapy as accelerated partial breast irradiation alone or as boost—GEC-ESTRO breast cancer working group practical recommendations. Radiother Oncol 128(3):411–420PubMed

85.

Kaiser J, Reitsamer R, Kopp P et al (2018) Intraoperative electron radiotherapy (IOERT) in the treatment of primary breast cancer. Breast Care 13(3):162–167PubMedPubMedCentral

86.

Veronesi U, Orecchia R, Luini A et al (2001) A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated. Eur J Cancer 37(17):2178–2183PubMed

87.

(2007) (RTOG) RTOG. NSABP PROTOCOL B‑39 / RTOG PROTOCOL 0413: A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) for Women with Stage 0, I, or II Breast Cancer. https://www.atcwustledu/protocols/nsabp/b-39/0413.pdf. Last access: 31 Jan 2018

Title: DEGRO practical guideline for partial-breast irradiation
Authors: V. Strnad
D. Krug
F. Sedlmayer
M. D. Piroth
W. Budach
R. Baumann
P. Feyer
M. N. Duma
W. Haase
W. Harms
T. Hehr
R. Fietkau
J. Dunst
R. Sauer
Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO)
Publication date: 01-09-2020
Publisher: Springer Berlin Heidelberg
Keywords: Brachytherapy
Breast Cancer
Breast Cancer
Published in: Strahlentherapie und Onkologie / Issue 9/2020
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI: https://doi.org/10.1007/s00066-020-01613-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

DEGRO practical guideline for partial-breast irradiation

Abstract

Purpose

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 9/2020

Modification of preoperative radiochemotherapy for esophageal cancer (CROSS protocol) is safe and efficient with no impact on surgical morbidity

Stellenwert der Hippocampusschonung bei therapeutischer Ganzhirnbestrahlung

Effect of hypofractionation on the incidental axilla dose during tangential field radiotherapy in breast cancer

Impact of 18F-FDG-PET/CT on the identification of regional lymph node metastases and delineation of the primary tumor in esophageal squamous cell carcinoma patients

Effect of lung volume on helical radiotherapy in esophageal cancer: are there predictive factors to achieve acceptable lung doses?

Adjuvant breast inversely planned intensity-modulated radiotherapy with simultaneous integrated boost for early stage breast cancer